These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26422099)

  • 1. Hormonal impact on tumor growth and progression.
    Reznikov A
    Exp Oncol; 2015 Sep; 37(3):162-72. PubMed ID: 26422099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consideration of GREB1 as a potential therapeutic target for hormone-responsive or endocrine-resistant cancers.
    Hodgkinson KM; Vanderhyden BC
    Expert Opin Ther Targets; 2014 Sep; 18(9):1065-76. PubMed ID: 24998469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of apoptosis regulators in tumorigenesis.
    Malaguarnera L
    Cancer Metastasis Rev; 2004; 23(3-4):367-87. PubMed ID: 15197336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs.
    Fleisch MC; Maxwell CA; Barcellos-Hoff MH
    Endocr Relat Cancer; 2006 Jun; 13(2):379-400. PubMed ID: 16728569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does microenvironment contribute to the etiology of estrogen receptor-negative breast cancer?
    Barcellos-Hoff MH
    Clin Cancer Res; 2013 Feb; 19(3):541-8. PubMed ID: 23325583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
    Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
    Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis.
    McCubrey JA; Abrams SL; Fitzgerald TL; Cocco L; Martelli AM; Montalto G; Cervello M; Scalisi A; Candido S; Libra M; Steelman LS
    Adv Biol Regul; 2015 Jan; 57():75-101. PubMed ID: 25453219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymes as modulators in malignant transformation.
    Vihko P; Herrala A; Härkönen P; Isomaa V; Kaija H; Kurkela R; Li Y; Patrikainen L; Pulkka A; Soronen P; Törn S
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):277-83. PubMed ID: 15860271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
    Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer.
    Flötotto T; Djahansouzi S; Gläser M; Hanstein B; Niederacher D; Brumm C; Beckmann MW
    Horm Metab Res; 2001 Aug; 33(8):451-7. PubMed ID: 11544557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).
    Zi F; He J; He D; Li Y; Yang L; Cai Z
    Mol Med Rep; 2015 May; 11(5):3203-11. PubMed ID: 25593080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms promoting physiological cells progression into tumorigenesis.
    Korbut E; Ptak-Belowska A; Brzozowski T
    J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Back to the beginning: The initiation of cancer.
    Cobaleda C; Sánchez-García I
    Bioessays; 2013 May; 35(5):413. PubMed ID: 23553938
    [No Abstract]   [Full Text] [Related]  

  • 18. The Long Evolutionary Journey of Cancer from Ancestor to Modern Humans.
    Carruba G; Trosko JE
    Crit Rev Oncog; 2017; 22(3-4):323-352. PubMed ID: 29604908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and markers of carcinogenesis and neoplastic progression.
    Bodey B; Bodey B; Siegel SE
    Expert Opin Biol Ther; 2005 Oct; 5(10):1317-32. PubMed ID: 16197337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential benefits of estrogens and progestogens on breast cancer.
    Schneider HP; Jackisch C
    Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.